Skip to main content
. 2017 Oct 3;14(6):7241–7249. doi: 10.3892/ol.2017.7129

Figure 3.

Figure 3.

Effects of p38 expression on the regulation of tumor cell sensitivity to thalidomide treatment. MTT assay for the survival rate of (A) Eca-109 and (B) TE-1 cells. (C) Flow cytometric apoptosis assay of Eca-109 and TE-1 cells. (D) Western blotting for Ku80 expression following treatment with or without thalidomide in cells with different p38 expression levels. (E) p38 expression in esophageal cancer cells is positively associated with IDO expression. Ku80, Ku autoantigen 80 kDa; p, phosphorylated; IDO, indoleamine 2,3-dioxygenase; FITC, fluorescein isothiocyanate; PI, propidium iodide.